Jason Kolbert


Maxim Shares Two Cents on AEterna Zentaris Inc. (USA) (AEZS) Following Positive Lead from EMA Pediatric Committee

Maxim analyst Jason Kolbert is optimistic on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) on the heels of the biotech firm indicating that the Pediatric …

This Analyst Has Had Enough with Galena Biopharma Inc (GALE)

Investors weren’t impressed with Galena Biopharma Inc (NASDAQ:GALE) latest announcement that CEO Dr. Mark Schwartz’s would stand down, and at least one analyst …

Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As Zoptrex Completes Enrollment

Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) jumped over 20% today, after the drug maker announced the completion of the clinical phase of …

How Healthcare Will Fare in a Trump Administration from the Eyes of Maxim

In the dawning of a new year and a new administration, healthcare investors cannot help but question as to what this will all …

Maxim Reiterates Buy on IntelliPharmaCeutics Intl Inc (USA) (IPCI) Following NDA Submission

In a research report issued Friday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ :IPCI), …

Maxim Reiterates Buy on Amedica Corporation (AMDA) After Discussion with Management

In a research report released Wednesday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Amedica Corporation (NASDAQ:AMDA), with a $5.00 price …

Maxim Pounds the Table on Amedica Corporation (AMDA)

After a third-quarter earnings release yesterday, Maxim analyst Jason Kolbert was out pounding the table on Amedica Corporation (NASDAQ:AMDA), reiterating a Buy rating …

Maxim Bullish on AEterna Zentaris Inc. (USA) (AEZS) After 3Q Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are jumping nearly 5% after the biotech firm posted third-quarter results yesterday that with a pivotal clinical …

Maxim Lifts Price Target on Oculus Innovative Sciences, Inc. (OCLS) Following Monetization of Latin America Dermatology Business

Oculus Innovative, Sciences, Inc. (NASDAQ:OCLS) shares were sent climbing 26% yesterday after the specialty pharmaceutical company announced the sale of its Latin America …

Maxim Reiterates Buy on Omeros Corporation (OMER) Following Positive Phase 2 Data in Renal Diseases

In a research report published Monday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Omeros Corporation (NASDAQ:OMER) with a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts